PROLONGATION OF POSTOPERATIVE DISEASE-FREE INTERVAL AND SURVIVAL IN HUMAN COLORECTAL CANCER BY B.C.G. OR B.C.G. PLUS 5-FLUOROURACIL
- 1 April 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 307 (7965) , 871-876
- https://doi.org/10.1016/s0140-6736(76)92093-6
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Preoperative irradiation for carcinoma of the rectum and rectosigmoid colon: Report of a national veterans administration randomized studyCancer, 1975
- Chemotherapy as an Adjuvant to Surgery for Colorectal CancerAnnals of Surgery, 1975
- Adjuvant therapy of cancer via the cellular immune mechanism or fibrin by induced fibrinolysis and oral anticoagulantsCancer, 1975
- A second look at the second look operation in colonic cancer after the administration of fluorouracilThe American Journal of Surgery, 1974
- Cancer of the colon in south saskatchewan.A population studyCancer, 1973
- Management of Adult Acute Myelogenous LeukaemiaBMJ, 1973
- Adjuvant chemotherapy with 5-fluorouracil in surgery for colorectal cancer: Eight-year progress reportDiseases of the Colon & Rectum, 1972
- PREOPERATIVE IRRADIATION OF RECTOSIGMOID CARCINOMA INCLUDING ITS REGIONAL LYMPH NODESAmerican Journal of Roentgenology, 1972
- Fluorouracil As an Adjuvant to Surgery in Carcinoma of the ColonArchives of Surgery, 1971
- Prevalence and prognosis of individual clinical and pathologic variables associated with colorectal carcinomaCancer, 1967